[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia-Pacific Cancer Treatment Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2022

January 2017 | 120 pages | ID: AE9BF471088EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Scope of the Report:

This report focuses on the Cancer Treatment Drugs in Asia
  • Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.

    Market Segment by Manufacturers, this report covers
    • Roche
    • Novartis
    • Celgene
    • Amgen
    • Johnson & Johnson
    • Bristol
    • Myers Squibb
    • Takeda
    • Eli Lilly
    • Pfizer
    • AstraZeneca
    • Astellas
    • Sanofi
    • Bayer
    • Merck & Co.
    • Biogen Idec
    • Kyowa Hakko Kirin
    • Otsuka
    • Teva
    • Eisai
    • Merck KGaA
    • Ipsen
    • AbbVie
    • Gilead Sciences
    Market Segment by Countries, covering
    • China
    • Japan
    • Korea
    • Taiwan
    • Southeast Asia
    • India
    • Australia
    Market Segment by Type, covers
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy (Biologic Therapy)
    • Hormonal Therapy
    • Others
    Market Segment by Applications, can be divided into
    • Blood Cancer
    • Breast Cancer
    • Gastrointestinal Cancer
    • Prostate Cancer
    • Respiratory/Lung Cancer
    • Other Cancers
    There are 19 Chapters to deeply display the Asia
  • Pacific Cancer Treatment Drugs market.

    Chapter 1, to describe Cancer Treatment Drugs Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the manufacturers of Cancer Treatment Drugs, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

    Chapter 4, to show the Asia
  • Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Cancer Treatment Drugs, for each country, from 2012 to 2017;

    Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

    Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application;

    Chapter 14, Cancer Treatment Drugs market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

    Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

    Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

    Chapter 17, to describe sales channel, distributors, traders, dealers etc.

    Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
  • 1 MARKET OVERVIEW

    1.1 Cancer Treatment Drugs Introduction
    1.2 Market Analysis by Type
      1.2.1 Chemotherapy
      1.2.2 Targeted Therapy
      1.2.3 Immunotherapy (Biologic Therapy)
      1.2.4 Hormonal Therapy
      1.2.5 Others
    1.3 Market Analysis by Applications
      1.3.1 Blood Cancer
      1.3.2 Breast Cancer
      1.3.3 Gastrointestinal Cancer
      1.3.4 Prostate Cancer
      1.3.5 Respiratory/Lung Cancer
      1.3.6 Other Cancers
    1.4 Market Analysis by Countries
      1.4.1 China Status and Prospect (2012-2022)
      1.4.2 Korea Status and Prospect (2012-2022)
      1.4.3 Japan Status and Prospect (2012-2022)
      1.4.4 Taiwan Status and Prospect (2012-2022)
      1.4.5 Southeast Asia Status and Prospect (2012-2022)
      1.4.6 India Status and Prospect (2012-2022)
      1.4.7 Australia Status and Prospect (2012-2022)
    1.5 Market Dynamics
      1.5.1 Market Opportunities
      1.5.2 Market Risk
      1.5.3 Market Driving Force

    2 MANUFACTURERS PROFILES

    2.1 Roche
      2.1.1 Profile
      2.1.2 Cancer Treatment Drugs Type and Applications
        2.1.2.1 Type
        2.1.2.2 Type
      2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.1.4 Business Overview
      2.1.5 Roche News
    2.2 Novartis
      2.2.1 Profile
      2.2.2 Cancer Treatment Drugs Type and Applications
        2.2.2.1 Type
        2.2.2.2 Type
      2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.2.4 Business Overview
      2.2.5 Novartis News
    2.3 Celgene
      2.3.1 Profile
      2.3.2 Cancer Treatment Drugs Type and Applications
        2.3.2.1 Type
        2.3.2.2 Type
      2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.3.4 Business Overview
      2.3.5 Celgene News
    2.4 Amgen
      2.4.1 Profile
      2.4.2 Cancer Treatment Drugs Type and Applications
        2.4.2.1 Type
        2.4.2.2 Type
      2.4.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.4.4 Business Overview
      2.4.5 Amgen News
    2.5 Johnson & Johnson
      2.5.1 Profile
      2.5.2 Cancer Treatment Drugs Type and Applications
        2.5.2.1 Type
        2.5.2.2 Type
      2.5.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.5.4 Business Overview
      2.5.5 Johnson & Johnson News
    2.6 Bristol-Myers Squibb
      2.6.1 Profile
      2.6.2 Cancer Treatment Drugs Type and Applications
        2.6.2.1 Type
        2.6.2.2 Type
      2.6.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.6.4 Business Overview
      2.6.5 Bristol-Myers Squibb News
    2.7 Takeda
      2.7.1 Profile
      2.7.2 Cancer Treatment Drugs Type and Applications
        2.7.2.1 Type
        2.7.2.2 Type
      2.7.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.7.4 Business Overview
      2.7.5 Takeda News
    2.8 Eli Lilly
      2.8.1 Profile
      2.8.2 Cancer Treatment Drugs Type and Applications
        2.8.2.1 Type
        2.8.2.2 Type
      2.8.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.8.4 Business Overview
      2.8.5 Eli Lilly News
    2.9 Pfizer
      2.9.1 Profile
      2.9.2 Cancer Treatment Drugs Type and Applications
        2.9.2.1 Type
        2.9.2.2 Type
      2.9.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.9.4 Business Overview
      2.9.5 Pfizer News
    2.10 AstraZeneca
      2.10.1 Profile
      2.10.2 Cancer Treatment Drugs Type and Applications
        2.10.2.1 Type
        2.10.2.2 Type
      2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.10.4 Business Overview
      2.10.5 AstraZeneca News
    2.11 Astellas
      2.11.1 Profile
      2.11.2 Cancer Treatment Drugs Type and Applications
        2.11.2.1 Type
        2.11.2.2 Type
      2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.11.4 Business Overview
      2.11.5 Astellas News
    2.12 Sanofi
      2.12.1 Profile
      2.12.2 Cancer Treatment Drugs Type and Applications
        2.12.2.1 Type
        2.12.2.2 Type
      2.12.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.12.4 Business Overview
      2.12.5 Sanofi News
    2.13 Bayer
      2.13.1 Profile
      2.13.2 Cancer Treatment Drugs Type and Applications
        2.13.2.1 Type
        2.13.2.2 Type
      2.13.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.13.4 Business Overview
      2.13.5 Bayer News
    2.14 Merck & Co.
      2.14.1 Profile
      2.14.2 Cancer Treatment Drugs Type and Applications
        2.14.2.1 Type
        2.14.2.2 Type
      2.14.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.14.4 Business Overview
      2.14.5 Merck & Co. News
    2.15 Biogen Idec
      2.15.1 Profile
      2.15.2 Cancer Treatment Drugs Type and Applications
        2.15.2.1 Type
    .2.2 Type
      2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.15.4 Business Overview
      2.15.5 Biogen Idec News
    2.16 Kyowa Hakko Kirin
      2.16.1 Profile
      2.16.2 Cancer Treatment Drugs Type and Applications
        2.16.2.1 Type
        2.16.2.2 Type
      2.16.3 Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.16.4 Business Overview
      2.16.5 Kyowa Hakko Kirin News
    2.17 Otsuka
      2.17.1 Profile
      2.17.2 Cancer Treatment Drugs Type and Applications
        2.17.2.1 Type
        2.17.2.2 Type
      2.17.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.17.4 Business Overview
      2.17.5 Otsuka News
    2.18 Teva
      2.18.1 Profile
      2.18.2 Cancer Treatment Drugs Type and Applications
        2.18.2.1 Type
        2.18.2.2 Type
      2.18.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.18.4 Business Overview
      2.18.5 Teva News
    2.19 Eisai
      2.19.1 Profile
      2.19.2 Cancer Treatment Drugs Type and Applications
        2.19.2.1 Type
        2.19.2.2 Type
      2.19.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.19.4 Business Overview
      2.19.5 Eisai News
    2.20 Merck KGaA
      2.20.1 Profile
      2.20.2 Cancer Treatment Drugs Type and Applications
        2.20.2.1 Type
        2.20.2.2 Type
      2.20.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.20.4 Business Overview
      2.20.5 Merck KGaA News
    2.21 Ipsen
      2.21.1 Profile
      2.21.2 Cancer Treatment Drugs Type and Applications
        2.21.2.1 Type
        2.21.2.2 Type
      2.21.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.21.4 Business Overview
      2.21.5 Ipsen News
    2.22 AbbVie
      2.22.1 Profile
      2.22.2 Cancer Treatment Drugs Type and Applications
        2.22.2.1 Type
        2.22.2.2 Type
      2.22.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.22.4 Business Overview
      2.22.5 AbbVie News
    2.23 Gilead Sciences
      2.23.1 Profile
      2.23.2 Cancer Treatment Drugs Type and Applications
        2.23.2.1 Type
        2.23.2.2 Type
      2.23.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
      2.23.4 Business Overview
      2.23.5 Gilead Sciences News

    3 ASIA-PACIFIC CANCER TREATMENT DRUGS MARKET COMPETITION, BY MANUFACTURER

    3.1 Asia-Pacific Cancer Treatment Drugs Sales and Market Share by Manufacturer (2016-2017)
    3.2 Asia-Pacific Cancer Treatment Drugs Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Asia-Pacific Cancer Treatment Drugs Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
      3.4.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share
      3.4.2 Top 5 Cancer Treatment Drugs Manufacturer Market Share
    3.5 Market Competition Trend

    4 ASIA-PACIFIC CANCER TREATMENT DRUGS MARKET ANALYSIS BY COUNTRIES/REGIONS

    4.1 Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries/Regions
    4.2 Asia-Pacific Cancer Treatment Drugs Sales by Countries/Regions (2012-2017)
    4.3 Asia-Pacific Cancer Treatment Drugs Revenue (Value) by Countries (2012-2017)

    5 ASIA-PACIFIC MARKET SEGMENTATION CANCER TREATMENT DRUGS BY TYPE

    5.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017)
      5.1.1 Asia-Pacific Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
      5.1.2 Asia-Pacific Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
    5.2 Chemotherapy Sales Growth and Price
      5.2.1 Asia-Pacific Chemotherapy Sales Growth (2012-2017)
      5.2.2 Asia-Pacific Chemotherapy Price (2012-2017)
    5.3 Targeted Therapy Sales Growth and Price
      5.3.1 Asia-Pacific Targeted Therapy Sales Growth (2012-2017)
      5.3.2 Asia-Pacific Targeted Therapy Price (2012-2017)
    5.4 Immunotherapy (Biologic Therapy) Sales Growth and Price
      5.4.1 Asia-Pacific Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)
      5.4.2 Asia-Pacific Immunotherapy (Biologic Therapy) Price (2012-2017)
    5.5 Hormonal Therapy Sales Growth and Price
      5.5.1 Asia-Pacific Hormonal Therapy Sales Growth (2012-2017)
      5.5.2 Asia-Pacific Hormonal Therapy Price (2012-2017)
    5.6 Others Sales Growth and Price
      5.6.1 Asia-Pacific Others Sales Growth (2012-2017)
      5.6.2 Asia-Pacific Others Price (2012-2017)

    6 ASIA-PACIFIC MARKET SEGMENTATION CANCER TREATMENT DRUGS BY APPLICATION

    6.1 Asia-Pacific Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    6.2 Blood Cancer Sales Growth (2012-2017)
    6.3 Breast Cancer Sales Growth (2012-2017)
    6.4 Gastrointestinal Cancer Sales Growth (2012-2017)
    6.5 Prostate Cancer Sales Growth (2012-2017)
    6.6 Respiratory/Lung Cancer Sales Growth (2012-2017)
    6.7 Other Cancers Sales Growth (2012-2017)

    7 CHINA CANCER TREATMENT DRUGS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    7.1 China Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
    7.2 China Cancer Treatment Drugs Sales and Market Share by Type
    7.3 China Cancer Treatment Drugs Sales by Application (2012-2017)
    7.4 China Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
      7.4.1 China Cancer Treatment Drugs Sales and Market Share by Manufacturer
      7.4.2 China Cancer Treatment Drugs Revenue and Market Share by Manufacturer
    7.5 China Cancer Treatment Drugs Export and Import (2012-2017)

    8 JAPAN CANCER TREATMENT DRUGS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    8.1 Japan Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
    8.2 Japan Cancer Treatment Drugs Sales and Market Share by Type
    8.3 Japan Cancer Treatment Drugs Sales by Application (2012-2017)
    8.4 Japan Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
      8.4.1 Japan Cancer Treatment Drugs Sales and Market Share by Manufacturer
      8.4.2 Japan Cancer Treatment Drugs Revenue and Market Share by Manufacturer
    8.5 Japan Cancer Treatment Drugs Export and Import (2012-2017)

    9 KOREA CANCER TREATMENT DRUGS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    9.1 Korea Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
    9.2 Korea Cancer Treatment Drugs Sales and Market Share by Type
    9.3 Korea Cancer Treatment Drugs Sales by Application (2012-2017)
    9.4 Korea Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
      9.4.1 Korea Cancer Treatment Drugs Sales and Market Share by Manufacturer
      9.4.2 Korea Cancer Treatment Drugs Revenue and Market Share by Manufacturer
    9.5 Korea Cancer Treatment Drugs Export and Import (2012-2017)

    10 TAIWAN CANCER TREATMENT DRUGS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    10.1 Taiwan Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
    10.2 Taiwan Cancer Treatment Drugs Sales and Market Share by Type
    10.3 Taiwan Cancer Treatment Drugs Sales by Application (2012-2017)
    10.4 Taiwan Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
      10.4.1 Taiwan Cancer Treatment Drugs Sales and Market Share by Manufacturer
      10.4.2 Taiwan Cancer Treatment Drugs Revenue and Market Share by Manufacturer
    10.5 Taiwan Cancer Treatment Drugs Export and Import (2012-2017)

    11 SOUTHEAST ASIA CANCER TREATMENT DRUGS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    11.1 Southeast Asia Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
    11.2 Southeast Asia Cancer Treatment Drugs Sales and Market Share by Type
    11.3 Southeast Asia Cancer Treatment Drugs Sales by Application (2012-2017)
    11.4 Southeast Asia Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
      11.4.1 Southeast Asia Cancer Treatment Drugs Sales and Market Share by Manufacturer
      11.4.2 Southeast Asia Cancer Treatment Drugs Revenue and Market Share by Manufacturer
    11.5 Southeast Asia Cancer Treatment Drugs Export and Import (2012-2017)

    12 INDIA CANCER TREATMENT DRUGS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    12.1 India Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
    12.2 India Cancer Treatment Drugs Sales and Market Share by Type
    12.3 India Cancer Treatment Drugs Sales by Application (2012-2017)
    12.4 India Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
      12.4.1 India Cancer Treatment Drugs Sales and Market Share by Manufacturer
      12.4.2 India Cancer Treatment Drugs Revenue and Market Share by Manufacturer
    12.5 India Cancer Treatment Drugs Export and Import (2012-2017)

    13 AUSTRALIA CANCER TREATMENT DRUGS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

    13.1 Australia Cancer Treatment Drugs Revenue, Sales and Growth Rate (2012-2017)
    13.2 Australia Cancer Treatment Drugs Sales and Market Share by Type
    13.3 Australia Cancer Treatment Drugs Sales by Application (2012-2017)
    13.4 Australia Cancer Treatment Drugs Sales, Revenue and Market Share by Manufacturer
      13.4.1 Australia Cancer Treatment Drugs Sales and Market Share by Manufacturer
      13.4.2 Australia Cancer Treatment Drugs Revenue and Market Share by Manufacturer
    13.5 Australia Cancer Treatment Drugs Export and Import (2012-2017)

    14 CANCER TREATMENT DRUGS MARKET FORECAST (2017-2022)

    14.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
    14.2 Cancer Treatment Drugs Market Forecast by Countries/Regions (2017-2022)
      14.2.1 China Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
      14.2.2 Japan Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
      14.2.3 Korea Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
      14.2.4 Taiwan Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
      14.2.5 Southeast Asia Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
      14.2.6 India Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
      14.2.7 Australia Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    14.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022)
    14.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022)

    15 CANCER TREATMENT DRUGS MANUFACTURING COST ANALYSIS

    15.1 Cancer Treatment Drugs Key Raw Materials Analysis
      15.1.1 Key Raw Materials
      15.1.2 Price Trend of Key Raw Materials
      15.1.3 Key Suppliers of Raw Materials
      15.1.4 Market Concentration Rate of Raw Materials
    15.2 Proportion of Manufacturing Cost Structure
      15.2.1 Raw Materials
      15.2.2 Labor Cost
      15.2.3 Manufacturing Expenses
    15.3 Manufacturing Process Analysis of Cancer Treatment Drugs

    16 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

    16.1 Cancer Treatment Drugs Industrial Chain Analysis
    16.2 Upstream Raw Materials Sourcing
    16.3 Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
    16.4 Downstream Buyers

    17 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

    17.1 Sales Channel
      17.1.1 Direct Marketing
      17.1.2 Indirect Marketing
      17.1.3 Marketing Channel Future Trend
    17.2 Distributors, Traders and Dealers

    18 RESEARCH FINDINGS AND CONCLUSION

    19 APPENDIX

    19.1 Methodology
    19.2 Analyst Introduction
    19.3 Data Source

    LIST OF TABLES AND FIGURES

    Figure Cancer Treatment Drugs Picture
    Table Product Specifications of Cancer Treatment Drugs
    Figure Asia-Pacific Sales Market Share of Cancer Treatment Drugs by Types in 2016
    Table Types of Cancer Treatment Drugs
    Figure Chemotherapy Picture
    Table Major Manufacturers of Chemotherapy
    Figure Targeted Therapy Picture
    Table Major Manufacturers of Targeted Therapy
    Figure Immunotherapy (Biologic Therapy) Picture
    Table Major Manufacturers of Immunotherapy (Biologic Therapy)
    Figure Hormonal Therapy Picture
    Table Major Manufacturers of Hormonal Therapy
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Asia-Pacific Cancer Treatment Drugs Sales Market Share by Applications in 2016
    Table Applications of Cancer Treatment Drugs
    Figure Blood Cancer Picture
    Figure Breast Cancer Picture
    Figure Gastrointestinal Cancer Picture
    Figure Prostate Cancer Picture
    Figure Respiratory/Lung Cancer Picture
    Figure Other Cancers Picture
    Figure China Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Korea Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Taiwan Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Australia Cancer Treatment Drugs Revenue (Million USD) and Growth Rate (2012-2022)
    Table Roche Basic Information, Manufacturing Base and Competitors
    Table Roche Cancer Treatment Drugs Type and Applications
    Table Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Novartis Basic Information, Manufacturing Base and Competitors
    Table Novartis Cancer Treatment Drugs Type and Applications
    Table Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Celgene Basic Information, Manufacturing Base and Competitors
    Table Celgene Cancer Treatment Drugs Type and Applications
    Table Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Amgen Basic Information, Manufacturing Base and Competitors
    Table Amgen Cancer Treatment Drugs Type and Applications
    Table Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table Johnson & Johnson Cancer Treatment Drugs Type and Applications
    Table Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
    Table Bristol-Myers Squibb Cancer Treatment Drugs Type and Applications
    Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Takeda Basic Information, Manufacturing Base and Competitors
    Table Takeda Cancer Treatment Drugs Type and Applications
    Table Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table Eli Lilly Cancer Treatment Drugs Type and Applications
    Table Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Pfizer Basic Information, Manufacturing Base and Competitors
    Table Pfizer Cancer Treatment Drugs Type and Applications
    Table Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table AstraZeneca Cancer Treatment Drugs Type and Applications
    Table AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Astellas Basic Information, Manufacturing Base and Competitors
    Table Astellas Cancer Treatment Drugs Type and Applications
    Table Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Sanofi Basic Information, Manufacturing Base and Competitors
    Table Sanofi Cancer Treatment Drugs Type and Applications
    Table Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Bayer Basic Information, Manufacturing Base and Competitors
    Table Bayer Cancer Treatment Drugs Type and Applications
    Table Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table Merck & Co. Cancer Treatment Drugs Type and Applications
    Table Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Biogen Idec Basic Information, Manufacturing Base and Competitors
    Table Biogen Idec Cancer Treatment Drugs Type and Applications
    Table Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
    Table Kyowa Hakko Kirin Cancer Treatment Drugs Type and Applications
    Table Kyowa Hakko Kirin Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Otsuka Basic Information, Manufacturing Base and Competitors
    Table Otsuka Cancer Treatment Drugs Type and Applications
    Table Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Teva Basic Information, Manufacturing Base and Competitors
    Table Teva Cancer Treatment Drugs Type and Applications
    Table Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Eisai Basic Information, Manufacturing Base and Competitors
    Table Eisai Cancer Treatment Drugs Type and Applications
    Table Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table Merck KGaA Cancer Treatment Drugs Type and Applications
    Table Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Ipsen Basic Information, Manufacturing Base and Competitors
    Table Ipsen Cancer Treatment Drugs Type and Applications
    Table Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table AbbVie Basic Information, Manufacturing Base and Competitors
    Table AbbVie Cancer Treatment Drugs Type and Applications
    Table AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
    Table Gilead Sciences Cancer Treatment Drugs Type and Applications
    Table Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    Table Asia-Pacific Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure Asia-Pacific Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure Asia-Pacific Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table Asia-Pacific Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Figure Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2017
    Table Asia-Pacific Cancer Treatment Drugs Price by Manufacturers (2016-2017)
    Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2015
    Figure Top 3 Cancer Treatment Drugs Manufacturer Market Share in 2016
    Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2015
    Figure Top 5 Cancer Treatment Drugs Manufacturer Market Share in 2016
    Figure Asia-Pacific Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Sales by Countries/Regions (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Sales Market Share by Countries (2012-2017)
    Figure Asia-Pacific 2012 Cancer Treatment Drugs Sales Market Share by Countries
    Figure Asia-Pacific 2016 Cancer Treatment Drugs Sales Market Share by Countries
    Figure Asia-Pacific Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Revenue by Countries (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Revenue Market Share by Countries (2012-2017)
    Table Asia-Pacific 2011 Cancer Treatment Drugs Revenue Market Share by Countries
    Table Asia-Pacific 2015 Cancer Treatment Drugs Revenue Market Share by Countries
    Table Asia-Pacific Cancer Treatment Drugs Sales by Type (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Sales Share by Type (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Revenue by Type (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Revenue Share by Type (2012-2017)
    Figure Europe Chemotherapy Sales Growth (2012-2017)
    Figure Europe Chemotherapy Price (2012-2017)
    Figure Europe Targeted Therapy Sales Growth (2012-2017)
    Figure Europe Targeted Therapy Price (2012-2017)
    Figure Europe Immunotherapy (Biologic Therapy) Sales Growth (2012-2017)
    Figure Europe Immunotherapy (Biologic Therapy) Price (2012-2017)
    Figure Europe Hormonal Therapy Sales Growth (2012-2017)
    Figure Europe Hormonal Therapy Price (2012-2017)
    Figure Europe Others Sales Growth (2012-2017)
    Figure Europe Others Price (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Sales by Application (2012-2017)
    Table Asia-Pacific Cancer Treatment Drugs Sales Share by Application (2012-2017)
    Figure Europe Blood Cancer Sales Growth (2012-2017)
    Figure Europe Breast Cancer Sales Growth (2012-2017)
    Figure Europe Gastrointestinal Cancer Sales Growth (2012-2017)
    Figure Europe Prostate Cancer Sales Growth (2012-2017)
    Figure Europe Respiratory/Lung Cancer Sales Growth (2012-2017)
    Figure Europe Other Cancers Sales Growth (2012-2017)
    Figure China Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Figure China Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table China Cancer Treatment Drugs Sales by Type (2012-2017)
    Table China Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
    Table China Cancer Treatment Drugs Sales by Application (2012-2017)
    Table China Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Table China Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure China Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure China Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table China Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure China Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2015
    Figure China Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Table China Cancer Treatment Drugs Export and Import (2012-2017)
    Figure Japan Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Figure Japan Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table Japan Cancer Treatment Drugs Sales by Type (2012-2017)
    Table Japan Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
    Table Japan Cancer Treatment Drugs Sales by Application (2012-2017)
    Table Japan Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Table Japan Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure Japan Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure Japan Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table Japan Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure Japan Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2015
    Figure Japan Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Table Japan Cancer Treatment Drugs Export and Import (2012-2017)
    Figure Korea Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Figure Korea Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table Korea Cancer Treatment Drugs Sales by Type (2012-2017)
    Table Korea Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
    Table Korea Cancer Treatment Drugs Sales by Application (2012-2017)
    Table Korea Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Table Korea Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure Korea Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure Korea Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table Korea Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure Korea Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2015
    Figure Korea Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Table Korea Cancer Treatment Drugs Export and Import (2012-2017)
    Figure Taiwan Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Figure Taiwan Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table Taiwan Cancer Treatment Drugs Sales by Type (2012-2017)
    Table Taiwan Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
    Table Taiwan Cancer Treatment Drugs Sales by Application (2012-2017)
    Table Taiwan Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Table Taiwan Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure Taiwan Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure Taiwan Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table Taiwan Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure Taiwan Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2015
    Figure Taiwan Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Table Taiwan Cancer Treatment Drugs Export and Import (2012-2017)
    Figure Southeast Asia Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Figure Southeast Asia Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales by Type (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales by Application (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Table Southeast Asia Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure Southeast Asia Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure Southeast Asia Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table Southeast Asia Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure Southeast Asia Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2015
    Figure Southeast Asia Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Table Southeast Asia Cancer Treatment Drugs Export and Import (2012-2017)
    Figure India Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Figure India Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table India Cancer Treatment Drugs Sales by Type (2012-2017)
    Table India Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
    Table India Cancer Treatment Drugs Sales by Application (2012-2017)
    Table India Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Table India Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure India Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure India Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table India Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure India Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2015
    Figure India Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Table India Cancer Treatment Drugs Export and Import (2012-2017)
    Figure Australia Cancer Treatment Drugs Revenue and Growth (2012-2017)
    Figure Australia Cancer Treatment Drugs Sales and Growth (2012-2017)
    Table Australia Cancer Treatment Drugs Sales by Type (2012-2017)
    Table Australia Cancer Treatment Drugs Sales Market Share by Type (2012-2017)
    Table Australia Cancer Treatment Drugs Sales by Application (2012-2017)
    Table Australia Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
    Table Australia Cancer Treatment Drugs Sales by Manufacturer (2016-2017)
    Figure Australia Cancer Treatment Drugs Sales Market Share by Manufacturer in 2016
    Figure Australia Cancer Treatment Drugs Sales Market Share by Manufacturer in 2017
    Table Australia Cancer Treatment Drugs Revenue by Manufacturer (2016-2017)
    Figure Australia Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2015
    Figure Australia Cancer Treatment Drugs Revenue Market Share by Manufacturer in 2016
    Table Australia Cancer Treatment Drugs Export and Import (2012-2017)
    Figure Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
    Table Asia-Pacific Cancer Treatment Drugs Sales Forecast by Countries/Regions (2017-2022)
    Table Asia-Pacific Cancer Treatment Drugs Market Share Forecast by Countries/Regions (2017-2022)
    Figure China Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    Figure Japan Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    Figure Korea Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    Figure Taiwan Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    Figure Southeast Asia Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    Figure India Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    Figure Australia Cancer Treatment Drugs Sales and Growth Rate Forecast (2017-2022)
    Table Asia-Pacific Cancer Treatment Drugs Sales Forecast by Type (2017-2022)
    Table Asia-Pacific Cancer Treatment Drugs Market Share Forecast by Type (2017-2022)
    Table Asia-Pacific Cancer Treatment Drugs Sales Forecast by Application (2017-2022)
    Table Asia-Pacific Cancer Treatment Drugs Market Share Forecast by Application (2017-2022)
    Table Sales Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Cancer Treatment Drugs
    Figure Manufacturing Process Analysis of Cancer Treatment Drugs
    Figure Cancer Treatment Drugs Industrial Chain Analysis
    Table Raw Materials Sources of Cancer Treatment Drugs Major Manufacturers in 2016
    Table Major Buyers of Cancer Treatment Drugs
    Table Distributors/Traders/ Dealers List


    More Publications